We are live on
!
Find out more
FPF
FNY Partners Fund Portfolio holdings
AUM
$185M
1-Year Est. Return
32.58%
This Fund
S&P 500
This Quarter
Est. Return
+14.16%
1 Year Est. Return
+32.58%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$588M
AUM Growth
+$175M
(+42%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
20.16%
Top 10 Holdings %
Top 10 Hldgs %
54.34%
Holding
835
New
294
Increased
101
Reduced
91
Closed
281
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
+$52.9M |
| 2 |
British American Tobacco
BTI
|
+$40.5M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$36.4M |
| 4 |
MFGP
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
|
+$22.3M |
| 5 |
ALR
Alere Inc
ALR
|
+$18.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AWH
Allied World Assurance Co Hld Lt
AWH
|
+$54.6M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$27.3M |
| 3 |
AABA
Altaba Inc
AABA
|
+$24.9M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
+$17.2M |
| 5 |
TechnipFMC
FTI
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.11% |
| 2 | Technology | 14.68% |
| 3 | Communication Services | 11.2% |
| 4 | Financials | 9.54% |
| 5 | Consumer Staples | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KITE
1
DELISTED
Kite Pharma, Inc.
KITE
| $68.2M | 11.61% |
+379,510
| New | +$52.9M |
|
|
TWX
2
DELISTED
Time Warner Inc
TWX
| $51M | 8.68% |
498,138
+358,491
| +257% | +$36.4M |
|
|
3
British American Tobacco
BTI
$121B
| $39.2M | 6.67% |
+628,077
| New | +$40.5M |
|
|
JHG
4
DELISTED
Janus Henderson
JHG
| $28.9M | 4.92% |
829,838
+181,190
| +28% | +$6.16M |
|
5
NXP Semiconductors
NXPI
$57B
| $28.3M | 4.82% |
250,258
-35,353
| -12% | -$3.94M |
|
|
ALR
6
DELISTED
Alere Inc
ALR
| $25M | 4.26% |
491,150
+374,427
| +321% | +$18.7M |
|
|
MFGP
7
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $22.3M | 3.79% |
+577,623
| New | +$22.3M |
|
8
Stellantis
STLA
$19.9B
| $21M | 3.57% |
1,170,341
-163,899
| -12% | -$2.27M |
|
|
KITE
9
CALL
DELISTED
Kite Pharma, Inc.
KITE
| $19M | 3.24% |
+2,827
| New | +$394K |
|
|
SHPG
10
DELISTED
Shire pic
SHPG
| $16.3M | 2.77% |
106,246
+66,695
| +169% | +$10.5M |
|
|
PRXL
11
DELISTED
Parexel International Corp
PRXL
| $10.2M | 1.74% |
116,340
+116,040
| +38,680% | +$10.2M |
|
12
Huntsman Corp
HUN
$1.69B
| $9.82M | 1.67% |
358,144
+82,490
| +30% | +$2.2M |
|
13
Herbalife
HLF
$1.29B
| $9.08M | 1.55% |
+267,800
| New | +$9.17M |
|
|
BRCD
14
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $8.53M | 1.45% |
714,000
+182,468
| +34% | +$2.25M |
|
|
AF
15
DELISTED
Astoria Financial Corporation
AF
| $8.26M | 1.4% |
+383,956
| New | +$7.63M |
|
16
ResMed
RMD
$34B
| $7.89M | 1.34% |
+102,553
| New | +$7.84M |
|
|
ALR.PRB
17
DELISTED
Alere Inc
ALR.PRB
| $7.33M | 1.25% |
18,282
+18,182
| +18,182% | +$7.15M |
|
18
Canadian Imperial Bank of Commerce
CM
$104B
| $7.24M | 1.23% |
165,408
-598
| -0.4% | -$25.6K |
|
|
DGI
19
DELISTED
DigitalGlobe Inc.
DGI
| $7.07M | 1.2% |
+200,556
| New | +$6.86M |
|
20
UBS Group
UBS
$166B
| $6.5M | 1.11% |
378,731
-16,800
| -4% | -$287K |
|
|
RICE
21
DELISTED
Rice Energy Inc.
RICE
| $6.13M | 1.04% |
+212,012
| New | +$5.79M |
|
22
BP
BP
$109B
| $5.79M | 0.98% |
166,996
-2,199
| -1% | -$69.9K |
|
23
Novartis
NVS
$294B
| $5.46M | 0.93% |
71,053
+41,479
| +140% | +$3.13M |
|
|
CPN
24
DELISTED
Calpine Corporation
CPN
| $5.39M | 0.92% |
+365,600
| New | +$5.22M |
|
25
TotalEnergies
TTE
$191B
| $5M | 0.85% |
93,400
| – | – |
|
Similar funds
USG2
PAM
HWP
IHM
EP
DVM
LCM
PAM
FNY Partners Fund's Q3 2017 Portfolio in Review
As of Q3 2017, FNY Partners Fund held 835 positions worth $588M, up 42% from $413M the previous quarter. Its ten largest holdings account for 54% of the portfolio.
FNY Partners Fund deployed $118M of net new capital in Q3 2017, opening 294 new positions and adding to 101 existing holdings. Its largest new stake was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 10% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Altaba Inc, an estimated $24.9M trimmed.
- FNY Partners Fund's largest Q3 2017 buy was Kite Pharma, Inc.: 379,510 shares worth $68.2M.
- FNY Partners Fund added most to Time Warner Inc in Q3 2017, an estimated $36.4M increase.
- FNY Partners Fund's biggest Q3 2017 reduction was Altaba Inc, cutting an estimated $24.9M.
- FNY Partners Fund fully exited Allied World Assurance Co Hld Lt in Q3 2017, selling an estimated $54.6M.
- FNY Partners Fund's ten largest holdings make up 54% of its $588M portfolio in Q3 2017.
- FNY Partners Fund opened 294 new positions and closed 281 in Q3 2017.
- FNY Partners Fund's portfolio value rose 42% quarter-over-quarter to $588M.
Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.